Financhill
Back

Cleveland-Cliffs, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
36

CLF
Cleveland-Cliffs, Inc.

Last Price:
$12.70
Seasonality Move:
8.94%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
36
Cleveland-Cliffs, Inc. (CLF) is a Sell

Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?

  • The current Cleveland-Cliffs, Inc. [CLF] share price is $12.39. The Score for CLF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CLF Stock Price Chart

What is Cleveland-Cliffs, Inc.'s stock price today?

  • The Cleveland-Cliffs, Inc. share price today is $12.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLF is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 52.96 Buy
Chaikin Money Flow: 5667278 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.55 - 12.55) Buy
Bollinger Bands (100): (10.32 - 12.96) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

CLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.7 Sell
20-day SMA: 11.83 Buy
50-day SMA: 12.43 Sell
200-day SMA: 9.93 Buy
8-day EMA: 12.46 Sell
20-day EMA: 12.19 Buy
50-day EMA: 12.01 Buy
200-day EMA: 11.1 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.72 per share, and an increase next year of $2.66 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Cleveland-Cliffs, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):